Answers are grounded in this paper and cite their sources.
INTRODUCTION: The aim of this study was to determine the reproductive health problems and chemotherapeutics’ handling processes among 2 groups of nurses, exposed and non-exposed.METHODS: In a tertiary hospital, all nurses (45) from 4 units who apply chemotherapeutics intensively (exposed), and 54 nurses who are not exposed chemotherapeutic drugs were questioned about reproductive health outcomes (RHO) and chemotherapeutic drug hendling process. Individuals selected from the records of the Occupational Health and Safety Unit by simple random sample method, and data collected via face-to-face interview technique using a questionnaire prepared by the researcher. In the analysis study group were examined for RHO, sociodemographic and work life characteristics, information on chemotherapeutic drug handling process exposure.RESULTS: Both groups were similar in terms of the frequency of stillbirths. However, congenital malformation was not seen in the non-exposed group, while it was 4.7% among exposed group; preterm delivery and spontaneous abortion were more frequent in the non-exposed (n=4; 10.5%) than exposed. Although results were not statistically significant, frequencies of RHO among the non-exposed group were higher. In the exposed group number of patients and chemotherapeutics handling were higher than regulated limits.DISCUSSION AND CONCLUSION: No differences of RHO problems observed among chemotherapeutic exposed and non-exposed nurses. In order to assess the relationship between RHO and chemotherapeutic exposure larger cohorts of healthcare workers should followed including data for handling process along with genotoxic, biological indicators
No takes yet. Share an insight, caveat, or question.
Eker et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: